Paracetamol 125 mg suppositories
Authorisation PA1113/004/004 · Phoenix Labs Unlimited Company
- Licence holder
- Phoenix Labs Unlimited Company (all products →)
- Active substance
- Paracetamol
- Clinical trials
- 23 clinical trials →
- Dosage form
- Suppository
- Route of administration
- Rectal use
- ATC codes
- N02BE, N02BE01
- First authorised
- 10/02/2012
- Prescription status
- Product not subject to medical prescription
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Paracetamol: supply and approvals
155 authorised products on the HPRA list contain Paracetamol. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- 1 supply notice, e.g. Azur compositum (16 Aug 2023 to 30 Dec 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 14 years (since 10 February 2012). The HPRA list marks it as marketed in Ireland.
Other medicines with Paracetamol in Ireland
154 other products on the HPRA list contain Paracetamol, from 37 licence holders; 85 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| BENYLIN Day & Night Tablets, 500mg/60mg tablets and 500/25mg film-coated tablets | JNTL Consumer Health (Ireland) Limited | National authorisation (PA) | Marketed |
| BENYLIN Day & Night Tablets, 500mg/60mg tablets and 500/25mg film-coated tablets | JNTL Consumer Health (Ireland) Limited | National authorisation (PA) | Marketed |
| Benylin Four Flu Film-Coated Tablets. Paracetamol 500mg Diphenhydramine hydrochloride 12.5mg Pseudoephedrine hydrochloride 22.5mg | JNTL Consumer Health (Ireland) Limited | National authorisation (PA) | Marketed |
| Calpol 120 mg/ 5 ml Sugar Free Infant Oral Suspension | JNTL Consumer Health (Ireland) Limited | National authorisation (PA) | Marketed |
| Calpol 120 mg/5 ml Infant Oral Suspension | JNTL Consumer Health (Ireland) Limited | National authorisation (PA) | Marketed |
| Calpol Six Plus 250 mg/5 ml Sugar/Colour Free Oral Suspension | JNTL Consumer Health I (Ireland) Limited | National authorisation (PA) | Marketed |
| Calpol Six Plus Fastmelts 250 mg Paracetamol orodispersible tablets | JNTL Consumer Health I (Ireland) Limited | National authorisation (PA) | Marketed |
| Co-codamol 15 mg/500 mg film-coated tablets | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Marketed |
| Codipar 15 mg/ 500 mg Capsules | Amdipharm Limited | National authorisation (PA) | Marketed |
| Combogesic 10 mg/ml Paracetamol + 3 mg/ml Ibuprofen solution for infusion | Jed Pharma Limited | National authorisation (PA) | Marketed |
| Dozol Oral Solution Paracetamol 120 mg/5 ml Diphenhydramine Hydrochloride 12.5 mg/5 ml | Phoenix Healthcare Ltd | National authorisation (PA) | Marketed |
| Easolief DUO Hot Drink 500 mg/150 mg powder for oral solution in sachet | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
Other substances in ATC group N02BE
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 15 other active substances share the group N02BE with this product:
Caffeine (15) · Phenylephrine hydrochloride (12) · Guaifenesin (8) · Ascorbic acid (8) · PSEUDOEPHEDRINE HYDROCHLORIDE (6) · Diphenhydramine hydrochloride (6) · Codeine phosphate hemihydrate (3) · Caffeine anhydrous (2) · Codeine phosphate bp (2) · BUCLIZINE HYDROCHLORIDE (2) · Ibuprofen (1) · Acetylsalicylic acid (1) · Promethazine hydrochloride (1) · Dextromethorphan hydrobromide (1) · Anhydrous caffeine (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Phoenix Labs Unlimited Company holds 30 products on the HPRA list, with 20 different active substances; 20 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.